Search

everythinglearnresearchcommunity

for

Search:↓

Photobiomodulation improves the quality of life for people with hair loss.

Acupressure improves quality of life in PCOS patients.

Hirsutism can lower a woman's quality of life, causing emotional distress and affecting social and work opportunities.

Some teenagers with anorexia nervosa have worse cognitive abilities, especially in visual and spatial tasks, and this is more common in those with a lower body weight.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Some medicinal plants can help heal wounds and may lead to new treatments.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Eyelashes protect the eyes, but more research is needed to understand how.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.